Company: ARWR
Filing Date: 2025-11-25
Form Type: 10-K
Source: 0000879407-25-000029
Chunk: 161

Company: ARROWHEAD PHARMACEUTICALS, INC.
Filing Date: 2025-11-25
Form: 10-K
Item: Item 8
Chunk 161
---
S 

The following documents are filed as part of this Annual Report on Form 10-K: 

(1)Financial Statements.

See Index to Financial Statements and Schedule on page F-1. 

(2)Financial Statement Schedules.

See Index to Financial Statements and Schedule on page F-1. All other schedules are omitted as the required information is not present or is not present in amounts sufficient to require submission of the schedule, or because the information required is included in the Consolidated Financial Statements or notes thereto. 

(3)Exhibits. 

The following exhibits are filed (or incorporated by reference herein) as part of this Annual Report on Form 10-K:

Incorporated by Reference HereinExhibitNumberDescriptionFormDate2.1†Stock and Asset Purchase Agreement between Arrowhead Research Corporation and Roche entities, dated October 21, 2011Annual Report on Form 10-K as Exhibit 2.1December 20, 20112.2†Asset Purchase and Exclusive License Agreement between Arrowhead Research Corporation and Novartis Institutes for BioMedical Research, Inc., dated March 3, 2015Quarterly Report on Form 10-Q, as Exhibit 2.1May 11, 20153.1Amended and Restated Certificate of IncorporationCurrent Report on Form 8-K as Exhibit 3.3April 6, 20163.2Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Arrowhead Pharmaceuticals, Inc.Quarterly Report on Form 10-Q, as Exhibit 3.2May 2, 20233.3Second Amended and Restated BylawsCurrent Report on Form 8-K as Exhibit 3.2January 30, 20234.1Form of Common Stock Certificate of Arrowhead Pharmaceuticals, Inc.Current Report on Form 8-K, as Exhibit 4.1April 6, 20164.2Form of IndentureRegistration Statement on Form S-3, as Exhibit 4.2December 2, 20194.3Rights Agreement dated as of March 21, 2017, between the Company and Computershare Trust Company, N.A., as rights agent, which includes as Exhibit B the Form of Rights CertificateCurrent Report on Form 8-K, as Exhibit 4.1March 23, 20174.4Description of Registrant’s SecuritiesAnnual Report on Form 10-K, as Exhibit 4.4November 25,